Kilitch Drugs to divest Ethiopian arm for $14 million
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
More news in Industry
Kobelco targets 8–10% topline growth as it launches three excavatorsCoforge net profit rises 56.5% as ‘record’ deal wins boost growth
Govt extends duty-free raw sugar import window till Dec 31 to ease festive supplies